THE Pharmacy Guild of Australia welcomes the opportunity to work with the Pharmaceutical Society of Australia on training and communications to support pharmacists on the upscheduling of pain relief medicines containing codeine leading up to 1 February 2018 and beyond.
Federal Government support, signed off by Federal Health Minister Greg Hunt last week, will allow the Guild and PSA to develop and deliver education, training, information and communications for community pharmacies, staff and patients nationally to enable a smooth transition to the upscheduling of codeine.
Both the Guild and PSA are committed to ensuring that community pharmacies and the pharmacist profession have rigorous, clinically-safe and patient-focused solutions in place to enable this change, which will have an impact on an estimated one million patients in 2018.
PSA and the Guild will collaborate to develop a comprehensive training package which includes five online modules encompassing protocols and procedures for pharmacists and pharmacy staff. Communication activities are also proposed to support community pharmacies to transition from codeine towards a broader 'pain management' approach, and to enable them to inform and support their patients.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Sep 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Sep 17